Vazalore
NDC Package 73089-081-14

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Vazalore is directionsDrink a full glass of water with each doseAdults and children 12 years and over: Take 1 or 2 capsules every 4 hours or 3 capsules every 6 hours while symptoms persistDo not exceed 12 capsules in 24 hoursChildren under 12 years consult a doctor. Marketed by Plx Pharma Inc, this product is identified by NDC 73089-081 and is authorized under FDA application NDA203697.

Identification & Billing

NDC Package Code
73089-081-14
Package Description
81 mg in 1 CARTON
Product Code
73089-081
11-Digit Billing Format
73089008114
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Vazalore
Dosage Form
-
Usage Information
DirectionsDrink a full glass of water with each doseAdults and children 12 years and over: Take 1 or 2 capsules every 4 hours or 3 capsules every 6 hours while symptoms persistDo not exceed 12 capsules in 24 hoursChildren under 12 years consult a doctor

Regulatory & Marketing

Labeler Name
Plx Pharma Inc
FDA Application #
NDA203697
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
08-05-2021
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (73089-081). Click a package code to view its specific billing and regulatory data.

73089-081-12
1 BLISTER PACK in 1 CARTON / 81 mg in 1 BLISTER PACK
73089-081-21
1 BOTTLE, PLASTIC in 1 CARTON / 81 mg in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73089-081-14 identifies a specific commercial package of 81 mg in 1 carton of Vazalore, labeled by Plx Pharma Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Plx Pharma Inc on August 05, 2021. The current certification is valid through December 31, 2025.

How is this Plx Pharma Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73089008114. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73089-081-14
11-Digit CMS (5-4-2)
73089-0081-14

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.